Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Name: Jamie D. Feusner - Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial
SKU: pb-42-1-feusner
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

SKU: pb-42-1-feusner Categories: Psychopharmacology Bulletin, VOL 42 No. 1 Articles Tags: alexander-bystritsky, generalized-anxiety-disorder, glutamate, jamie-d-feusner, lauren-kerwin, medworks-media, memantine, nmda-receptor, no-1, obsessive-compulsive-disorder, psychopharmacology-bulletin, sanjaya-saxena, volume-42

Description

Description

Jamie D. Feusner Link

ORIGINAL RESEARCH

Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Jamie D. Feusner, Lauren Kerwin, Sanjaya Saxena, Alexander Bystritsky

MWM-PSB-42-01-2009-FEUSNER

Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Description

Jamie D. Feusner Link

ORIGINAL RESEARCH

Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Jamie D. Feusner, Lauren Kerwin, Sanjaya Saxena, Alexander Bystritsky

Clozapine Related Suicidal Obsession by Branka Aukst-Margetic

Clinical Predictors of Response to Clozapine by Rajkumar A.P.

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

Jamie D. Feusner – Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Description

Jamie D. Feusner Link

ORIGINAL RESEARCH

Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs.Generalized Anxiety Disorder: An Open-Label Trial

Jamie D. Feusner, Lauren Kerwin, Sanjaya Saxena, Alexander Bystritsky

Related products

Clozapine Related Suicidal Obsession by Branka Aukst-Margetic

Clinical Predictors of Response to Clozapine by Rajkumar A.P.

Quetiapine XR Negative Clinical Trials Report by Gang Wang

Paliperidone Double-blind, Placebo- and Active-Controlled, Study